Portal Biliopathy

Portal Biliopathy: Comprehensive Structured Summary

Lecture by Prof. Yogesh Chawla, MD, DM

1. Main Clinical Topic(s) Discussed

Portal biliopathy (also termed portal cavernoma cholangiopathy) refers to abnormalities of the biliary system — predominantly extrahepatic, with or without intrahepatic involvement — resulting from extrahepatic portal vein obstruction (EHPVO) leading to portal cavernoma formation and subsequent common bile duct (CBD) compression and ischemic injury.

2. Key Learning Points, Guidelines, and Recommendations

Definition & Pathophysiology

• First described in 1944; modern clinical relevance highlighted after a landmark 1989–1992 case report demonstrating biliary obstruction reversal following surgical portal decompression
• Two critical pathophysiological mechanisms:

- Compression by dilated pericholedochal venous plexus (plexus of Petren) → reversible indentation/scalloping of bile duct

- Ischemic stricturing from thrombosis of small arterioles/venules supplying the bile duct → irreversible fibrotic strictures

- Secondary infection → subclinical cholangitis → inflammation, neoangiogenesis, and fibrosis compound biliary injury

• The pericholedochal plexus of Petren (parallel collateral vessels) is the primary driver of biliary abnormalities; the epicholedochal plexus of Saint is less implicated
• The infraduodenal bile duct is least vascularized and most prone to ischemic injury

Nomenclature

• Multiple historical terms: pseudosclerosing cholangitis, portal ductopathy, portal hypertensive biliopathy
• Indian National Association for Study of Liver (INASL) recommended: *"Portal Cavernoma Cholangiopathy"*
• Also occurs (less extensively described) in cirrhosis and non-cirrhotic portal fibrosis (NCPF)

Classification Systems

• By Location (Sarin's group):

- Type 1: Extrahepatic involvement only

- Type 2: Intrahepatic involvement only

- Type 3A: Extrahepatic + unilateral intrahepatic

- Type 3B: Extrahepatic + bilateral intrahepatic

• By Severity:

- Grade 1: Irregularities and angulations

- Grade 2: Strictures without dilation

- Grade 3: Strictures with upstream dilation

• By Type (Japanese classification): Varicoid, fibrotic, or mixed

Diagnostic Approach

• Screening: Ultrasound with Doppler — identifies portal cavernoma, serpiginous collaterals, biliary dilation, gallbladder varices, choledocholithiasis
• Gold standard: MRCP with portography — delineates both biliary and vascular anatomy non-invasively; differentiates stones from varices; provides roadmap for intervention
• CT scan: No longer preferred due to repeated radiation exposure
• ERCP: Reserved for therapeutic intervention only (not diagnostic)
• Endoscopic ultrasound (EUS): Superior to MRCP for distinguishing CBD stones from varices; useful pre-endotherapy planning
• Diagnosis requires: Portal cavernoma on imaging + characteristic cholangiographic alterations + exclusion of PSC, cholangiocarcinoma, biliary ascariasis, IgG4 cholangiopathy, HIV cholangiopathy

3. Specific Clinical Data, Statistics, and Study Results Cited